Firstly, unlike p53, TAp73 is rarely mutated but has been suggested to be overexpressed in a variety of cancers such as breast cancer [15,16], bladder cancer [17], prostate cancer [18], and colorectal cancer [19], amongst others [20,21], alluding to the possibility of a diametrically opposite function to tumor suppression. Here, TP53 is linked to neoplasm.